Rize Oncology Inc.
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -265.60K | -170.20K | -128.70K | -107.80K | -144.20K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 18.20K | -1.90K | 20.10K | 1.90K | 3.50K |
| Change in Net Operating Assets | -112.40K | 73.10K | 29.70K | -103.40K | 62.00K |
| Cash from Operations | -359.80K | -99.00K | -79.00K | -209.30K | -78.70K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 347.50K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 347.50K | -- | -- | -- |
| Foreign Exchange rate Adjustments | -1.70K | -52.60K | 13.90K | -12.10K | -32.20K |
| Miscellaneous Cash Flow Adjustments | -- | 0.00 | 0.00 | 0.00 | -- |
| Net Change in Cash | -361.50K | 195.90K | -65.10K | -221.40K | -110.90K |